Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway-Reference-Cited by-同舟云学术

Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway

Published:2010-05-11 Issue:15 Volume:116 Page:3603-3613
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ai Zhihong,Wang Juan,Wang Yudong,Lu Lihua,Tong Jianqian,Teng Yincheng

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25220/fullpdf

Reference32 articles.

1. Novel molecular profiles of endometrial cancer-new light through old windows;Doll;J Steroid Biochem Mol Biol.,2008

2. Cancer statistics, 2004;Jemal;CA Cancer J Clin.,2004

3. Endocrine therapy of endometrial cancer;Lentz;Cancer Treat Res.,1998

4. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma;Jadoul;Fertil Steril.,2003

5. Outcome of fertility-preserving treatment in young women with endometrial carcinomas;Niwa;BJOG.,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia;Frontiers in Endocrinology;2024-01-05

2. Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy;Gynecologic and Obstetric Pathology;2024

3. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway;Journal of Gynecologic Oncology;2024

4. Advances in the molecular mechanisms underlying progestin resistance in endometrial cancer;Fundamental Research;2023-09

5. Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma;Cancers;2022-12-15